The Mounjaro starting dose is 2.5 mg injected once weekly for the first four weeks. It is deliberately low — not designed to control blood sugar but to let your gut adapt to tirzepatide before you move to therapeutic doses. Side effects are usually mild at this stage. After four weeks, most people step up to 5 mg, then continue every four weeks toward a maintenance dose of 5, 10, or 15 mg.
What 2.5 mg of Mounjaro Looks Like
- Single-use prefilled pen labeled 2.5 mg in a four-pack monthly carton
- Color-coded so the dose is easy to identify
- Single-dose pen — one click delivers the full 2.5 mg
- Subcutaneous injection in abdomen, thigh, or upper arm
- Same day each week, any time of day
The First-Month Schedule
| Week | Dose | Common Experience |
|---|---|---|
| 1 | 2.5 mg | Mild appetite reduction; small first-injection nausea possible |
| 2 | 2.5 mg | Side effects often peak then fade; fullness sets in earlier at meals |
| 3 | 2.5 mg | Most side effects resolved; mild improvement in fasting glucose possible |
| 4 | 2.5 mg | Final starter week; clinician evaluates readiness for 5 mg |
Why Mounjaro Starts at 2.5 mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Both pathways slow gastric emptying — food stays in the stomach longer, which produces fullness but can also cause nausea and reflux. The 2.5 mg dose is calibrated to:
- Initiate the slowing of gastric emptying gradually
- Allow the gut to adapt without overwhelming GI symptoms
- Reduce dropout from severe early nausea or vomiting
- Establish a baseline experience before therapeutic dosing
Common Side Effects at the Starting Dose
| Side Effect | Frequency at 2.5 mg | Typical Duration |
|---|---|---|
| Mild nausea | 10–18 percent | 1–3 days after injection, fading over weeks |
| Decreased appetite | 30–40 percent | Persistent (intended effect) |
| Constipation | 5–8 percent | Manageable with hydration and fiber |
| Diarrhea | 5–10 percent | Often resolves in 1–2 weeks |
| Fatigue | 4–6 percent | Usually fades by week 3 |
| Injection site reaction | 2–4 percent | Resolves in 2–7 days |
How to Take Your First Dose
- Take the pen out of the refrigerator 15 to 30 minutes before injecting to warm to room temperature
- Wash your hands
- Choose an injection site (abdomen at least two inches from the navel, thigh, or back of upper arm)
- Clean the skin with an alcohol wipe; let it dry
- Remove the gray base cap of the pen
- Press the pen flat against the skin — needle becomes visible only after pressure
- Press the purple button until you hear two clicks
- Hold against the skin for 5 to 10 seconds to ensure full delivery
- Lift, dispose of the pen in a sharps container
What Mounjaro Does at the Starter Dose
- Slows gastric emptying — food stays in the stomach longer
- Mildly reduces appetite, especially for snacks and large meals
- Slight reduction in fasting and post-meal glucose for some users
- Modest weight loss (1 to 4 pounds across the four weeks)
- Establishes physiological baseline for higher doses
When to Call Your Clinician During the Starter Phase
- Severe abdominal pain (especially radiating to back) — possible pancreatitis
- Vomiting that prevents fluid intake for more than 24 hours
- Severe persistent nausea unresponsive to dietary changes
- Signs of dehydration (dizziness, very dark urine, headache)
- Signs of allergic reaction (rash, swelling, difficulty breathing)
- Diabetic patients on insulin or sulfonylurea: low blood sugar episodes
Stepping Up to 5 mg
At week 5, your prescriber will typically have you increase to the 5 mg pen — a separate prescription. You take 5 mg on what would be your next regular weekly day. The same titration logic applies: if 5 mg is harder than expected, hold there longer rather than rushing to 7.5 mg. See our guide on treatment options for the full Mounjaro dose ladder.
Storage and Travel
- Refrigerate unopened pens at 36 to 46 F
- Once in use (single dose anyway), discard after use
- For short-term storage out of the fridge, room temperature under 86 F is acceptable for up to 21 days for unopened Mounjaro
- Never freeze; discard if frozen
- Carry pens in cabin baggage for flights — never checked luggage
Related Reading
For more on tirzepatide and GLP-1 weight-loss medications, see our overviews of treatment options and prediabetes basics.
The Bottom Line
The Mounjaro starting dose is 2.5 mg once weekly for four weeks. It is intentionally subtherapeutic — it is meant to let your gut adapt to tirzepatide gradually before therapeutic dosing begins at 5 mg. Most people experience mild appetite reduction, occasional nausea, and modest weight loss during this period. Use the same day each week, take the pen out of the fridge to warm it before injecting, and rotate sites between abdomen, thigh, and upper arm. Call your clinician for severe abdominal pain, persistent vomiting, dehydration, or allergic symptoms. Step up to 5 mg only when you tolerate the starting dose well.
